<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05056987</url>
  </required_header>
  <id_info>
    <org_study_id>CLY935-C018</org_study_id>
    <nct_id>NCT05056987</nct_id>
  </id_info>
  <brief_title>Clinical Assessment of Two Daily Wear Reusable Soft Silicone Hydrogel Contact Lenses</brief_title>
  <official_title>Clinical Assessment of Two Daily Wear Reusable Soft Silicone Hydrogel Contact Lenses</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Alcon Research</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Alcon Research</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The overall objective of this clinical study is to describe the clinical performance of the&#xD;
      TOTAL30 soft contact lens compared to the ACUVUE OASYS with HYDRACLEAR PLUS (AOHP) soft&#xD;
      contact lens in a daily wear modality.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Subjects will be expected to attend 3 visits and wear the study contact lenses at least 5&#xD;
      days per week and at least 8 hours per day. On Visits 2 and 3, subjects will be expected to&#xD;
      wear the study lenses at least 6 hours prior to the study visit. The expected total duration&#xD;
      of subject participation in the study will be approximately 1.5 months. This study will be&#xD;
      conducted in the United Kingdom (UK).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">December 2021</start_date>
  <completion_date type="Anticipated">June 2022</completion_date>
  <primary_completion_date type="Anticipated">June 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Distance VA (logMAR) with study lenses</measure>
    <time_frame>Up to Day 28, each wear period</time_frame>
    <description>Distance visual acuity (VA) will be assessed for each eye individually with study lenses in place and measured in logarithm minimum angle of resolution (logMAR).</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">36</enrollment>
  <condition>Refractive Errors</condition>
  <arm_group>
    <arm_group_label>TOTAL30, then AOHP</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Lehfilcon A contact lenses worn first, with senofilcon A contact lenses worn second, as randomized. The lehfilcon A contact lenses will be worn for approximately 28 days. The senofilcon A contact lenses will be worn for approximately 14 days. Each product will be worn bilaterally (in both eyes) in a daily wear modality, with AOSEPT PLUS with HydraGlyde used for nightly cleaning and disinfection.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>AOHP, then TOTAL30</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Senofilcon A contact lenses worn first, with lehfilcon A contact lenses worn second, as randomized. The senofilcon A contact lenses will be worn for approximately 14 days. The lehfilcon A contact lenses will be worn for approximately 28 days. Each product will be worn bilaterally (in both eyes) in a daily wear modality, with AOSEPT PLUS with HydraGlyde used for nightly cleaning and disinfection.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Lehfilcon A contact lenses</intervention_name>
    <description>CE-marked spherical soft contact lenses worn according to to the product package insert/Instructions for Use</description>
    <arm_group_label>AOHP, then TOTAL30</arm_group_label>
    <arm_group_label>TOTAL30, then AOHP</arm_group_label>
    <other_name>TOTAL30®</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Senofilcon A contact lenses</intervention_name>
    <description>CE-marked spherical soft contact lenses worn according to to the product package insert/Instructions for Use</description>
    <arm_group_label>AOHP, then TOTAL30</arm_group_label>
    <arm_group_label>TOTAL30, then AOHP</arm_group_label>
    <other_name>ACUVUE OASYS® with HYDRACLEAR® Plus</other_name>
    <other_name>AOHP</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>AOSEPT PLUS with HydraGlyde</intervention_name>
    <description>Hydrogen peroxide-based cleaning and disinfecting solution</description>
    <arm_group_label>AOHP, then TOTAL30</arm_group_label>
    <arm_group_label>TOTAL30, then AOHP</arm_group_label>
    <other_name>AOSEPT® PLUS with HYDRAGLYDE®</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Key Inclusion Criteria:&#xD;
&#xD;
          -  Currently wearing any commercial spherical soft contact lenses with at least 3 months&#xD;
             wearing experience.&#xD;
&#xD;
          -  Willing to wear the study lenses for a minimum of 5 days per week and 8 hours per day.&#xD;
&#xD;
          -  Willing to NOT use rewetting/lubricating drops at any time during the study.&#xD;
&#xD;
          -  Other protocol-defined inclusion criteria may apply.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Participation in a clinical trial within the previous 14 days or currently enrolled in&#xD;
             any clinical trial.&#xD;
&#xD;
          -  Habitual AOHP contact lens wearers (in the past 3 months).&#xD;
&#xD;
          -  Monovision wear during the study.&#xD;
&#xD;
          -  Other protocol-defined exclusion criteria may apply.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Clinical Trial Lead, Vision Care</last_name>
    <role>Study Director</role>
    <affiliation>Alcon Research, LLC</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Alcon Call Center</last_name>
    <phone>1-888-451-3937</phone>
    <email>alcon.medinfo@alcon.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Alcon Investigator 8137</name>
      <address>
        <city>Manchester</city>
        <zip>M13 9PL</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>September 15, 2021</study_first_submitted>
  <study_first_submitted_qc>September 23, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 27, 2021</study_first_posted>
  <last_update_submitted>November 16, 2021</last_update_submitted>
  <last_update_submitted_qc>November 16, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 17, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Contact Lenses</keyword>
  <keyword>Myopia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Refractive Errors</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

